Navigation Links
Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent
Date:12/14/2010

HAYWARD, Calif., Dec. 14, 2010 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal auto-immune responses and inflammation, has selected the Merck BioManufacturing Network in the UK, to manufacture the large scale GMP clinical and pre-commercial supplies of A-623, an investigational novel peptibody in development for a number of autoimmune diseases.

"Establishing a rapid and high quality supply of A-623 for our current and future clinical programs is a critical element of our strategic plan and provides a number of potential development options," stated Paul F. Truex, President and Chief Executive Officer of Anthera. "The selection of the Merck BioManufacturing Network provides world-class, large molecule manufacturing capabilities at all stages of production with the necessary expertise to accelerate the development of A-623 in Systemic Lupus Erythematosus and other autoimmune diseases."

Steve Bagshaw, Site General Manager of the Merck BioManufacturing Network, said, "We are delighted that Anthera has chosen to work with us, recognizing our many years of development experience in microbial biologics and our capacity that offers appropriate scales for their manufacturing needs."   A-623 will be manufactured in the Billingham, UK facility of the Network.

A-623 is a novel peptibody inhibitor of B-Cell activating factor – a promoter of B-Cell survival in humans.  Abnormal levels of soluble and membrane BAFF and resulting B-Cell elevations have been implicated in a number of autoimmune diseases including systemic lupus erythematosus, Sjogren's Syndrome and rheumatoid arthritis. Anthera has previously begun enrollment in PEARL-SC, a Phase 2b clinical study in Lupus patients.  The PEARL-SC study (A Randomized, Double-Blind Phase 2b Stud
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Announces Update Call Regarding Vial Problems
2. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
3. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
4. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
5. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
6. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
7. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
8. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
9. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
10. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
11. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced that Steven A. Kriegsman ... David Haen , Vice President of Business Development ... at two significant investment conferences in September, 2015 ... FBR & Co. Second Annual Health Conference and ...
(Date:9/1/2015)... , Aug. 31, 2015 Research and Markets ... "Regulatory Affairs for Support Staff (London, UK - ... This two day course provides an introduction ... development and has been designed specifically for those working ... will gain an overview of EU regulatory procedures required ...
(Date:9/1/2015)... WAYNE, Pa. , Sept. 1, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced that researchers will be  presenting scientific data ... Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, ... in development, at PainWeek 2015 to ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
... recently enacted standard has replaced the Statement on Auditing ... Statement on Standards for Attestation Engagements No. 16 (SSAE ... service organizations to enforce a stronger set of controls ... http://photos.prnewswire.com/prnh/20080206/AQW030LOGO-b ) Rising Medical Solutions has taken ...
... FRANCISCO, Sept. 23, 2011 BASIS Science, Inc. today ... band due to launch later this year. The Basis ... health tracker with a web-based personal dashboard to help ... http://photos.prnewswire.com/prnh/20110923/LA74085 ) "With ongoing concerns about ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3BASIS Reveals Details of Heart Rate and Health Tracker; Plans to Showcase Basis Band at Health 2.0 2
(Date:9/2/2015)... FRANCE (PRWEB) , ... September 02, 2015 , ... ... , PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth ... This new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil ...
(Date:9/2/2015)... ... 2015 , ... Pentec Health, Inc., a national leader in outsourced pharmacy services, ... consecutive year. Less than 5 % of this year’s 5000 honorees share the “six-time” ... Pentec’s 3-year revenue growth rate of 65% sustained its most recent achievement. As an ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/1/2015)... Spring Lake, NJ (PRWEB) , ... September 01, ... ... physician, has a reputation for the telling the truth about medicine and health, ... has created a video blog, where he plans to regularly debunk certain misconceptions ...
(Date:9/1/2015)... ... 01, 2015 , ... September is National Prostate Cancer Awareness Month and Florida ... men each year in the United States. , Prostate cancer is to men what ... affecting 1 in 7 men. One new case occurs every 2.3 minutes and a ...
Breaking Medicine News(10 mins):Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... conducted survey has revealed that Irish hospitals are definitely ... ,The study carried out between February and ... Infection Society //looked into 75,000 cases has revealed that ... contracted during the stay at health centers across Ireland. ...
... fresh out of the college, are yet to land a permanent ... which sought responses from 500 newly qualified nurses and more than ... yet ended for a band 5 nursing job, which is the ... sentiment among nearly 86% of the nurses, who were not positive ...
... prefer not step in to fast-track a merger between Albury-Wodonga's ... with Tony Abbott and Goulburn Murray politicians yesterday. ,A ... governments has still not revealed a common plan towards working ... work as one. ,Mr Abbott states that the must ...
... According to researchers, stress among youth associated with parental ... ,The researchers at the John Moores University in Liverpool ... at times parents in recognizing the physical and emotional ... poor physical and mental health. ,According to ...
... Cancer drug Velcade has been banned in England because the ... Excellence (NICE) has refused// to fund treatment, according to last ... week that Velcade should not be offered on the NHS ... Presently a course of Velcade has been estimated to cost ...
... All batches of the paracetamol tablet Paratabs 500mg are being ... contamination which is most likely to be mould//. This applies ... could not have purchased the product without a prescription , ... their pharmacy and not to consume anymore Paratabs, while ...
Cached Medicine News:Health News:Stress brings about early onset of puberty 2
... standard, corrected curve trial lenses are ground with ... Marco refractors and are invaluable in treating low ... other manufacturers contain a disproportionately large number of ... expensive to produce, and fewer lenses in the ...
The LM-990A is the most completely automatic lensemeter ever created. It even measured monocular and binocular PD automatically....
... has made the LM-770 the easiest ... Technicians can be trained to operate ... instruction. The instrument tells the user ... A flashing indicator alerts the user ...
... designed to perform precise and accurate ... one-third the space of traditional examinations. ... refractors, automatic or digital lensmeters and ... EPIC enables the operator to call ...
Medicine Products: